Cargando…
Evolving perspectives of the role of novel agents in androgen-independent prostate cancer
Metastatic androgen-independent prostate cancer presents an intriguing clinical challenge, with a subtle interaction between hormone-responsive and refractory tumor cell elements. The treatment of advanced prostate carcinoma, which had remained stagnant for several decades following the understandin...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684340/ https://www.ncbi.nlm.nih.gov/pubmed/19468458 http://dx.doi.org/10.4103/0970-1591.42609 |